NCT04924699 2023-03-17A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast CancerShanghai Miracogen Inc.Phase 2/3 Unknown350 enrolled
NCT05280444 2022-12-29Lipiodol-TACE With Idarubicin for Hepatocellular CarcinomaZhongda HospitalPhase 2/3 Unknown216 enrolled